Updated: AstraZeneca settles with HMRC for £505 million
February 24, 2010
An eagerly awaited UK transfer pricing case will not now go to court.
AstraZeneca, the pharmaceutical company, has settled a transfer pricing dispute with the UK tax authorities, covering claims against the company going back over 15 years.
Sorry. You must be a subscriber to view this article. Alternatively, why not take a free trial? To subscribe and access this article immediately simply click here or call +44(0)207 779 8380.